Repressive effect of the phytoestrogen genistein on estradiol-induced uterine leiomyoma cell proliferation

Gynecological Endocrinology

Volumn 25, Issue 6, 2009, Pages 403-409

  Miyake, Asako ^a   Takeda, Takashi ^a   Isobe, Aki ^a   Wakabayashi, Atsuko ^a   Nishimoto, Fumihito ^a   Morishige, Ken Ichirou ^a   Sakata, Masahiro ^a   Kimura, Tadashi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

BADGE; Genistein; PPAR ; Signal transduction; Uterine leiomyoma

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ESTRADIOL; ESTROGEN RECEPTOR; GENISTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL COUNT; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TUMOR CELL; UTERUS MYOMA; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; ESTRADIOL; FEMALE; GENISTEIN; LEIOMYOMA; LIGANDS; PHYTOESTROGENS; PPAR GAMMA; RATS; RECEPTORS, ESTROGEN; UTERINE NEOPLASMS;

EID: 70350593983     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590902730804     Document Type: Article

References (25)

1. Wilcox LS, Koonin LM, Pokras R, Strauss LT, Xia Z, Peterson HB. Hysterectomy in the United States,1988-1990. Obstet Gynecol 1994;83:549-555.
2. Lepine LA, Hillis SD, Marchbanks PA, Koonin LM,Morrow B, Kieke BA, Wilcox LS. Hysterectomy surveillance - United States,1980-1993.MMWRCDC Surveill Summ 1997;46:1-15.
3. Walker CL, Stewart EA. Uterine fibroids: the elephant in the room. Science 2005;308:1589-1592.
4. Rein MS. Advances in uterine leiomyoma research: the progesterone hypothesis. Environ Health Perspect 2000;108 (5 Suppl):791-793.
5. Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 2003; 111:1037-1054.
6. Heim M, Frank O, Kampmann G, Sochocky N, Pennimpede T, Fuchs P, Hunziker W, Weber P, Martin I, Bendik I. The phytoestrogen genistein enhances osteogenesis and represses adeipogenic differentiation of human primary bone marrow stromal cells. Endocrinology 2004;145:848-859.
7. Konstantakopoulos N, Montgomery KG, Chamberlain N, Quinn MA, Baker MS, Rice GE, Georgiou HM, Campbell IG. Changes in gene expressions elicited by physiological concentrations of genistein on human endometrial cancer cells. Mol Carcinog 2006;45:752-763.
8. Moore AB, Castro L, Yu L, Zheng X, Di X, Sifre MI, Kissling GE, Newbold RR, Bortner CD, Dixon D. Stimulatory and inhibitory effects of genistein on human uterine leiomyoma cell proliferation are influenced by the concentration. Hum Reprod 2007;22:2623-2631.
9. Nagata C, Takatsuka N, KawakamiN, Shimizu H. Soy product intake and premenopausal hysterectomy in a follow-up study of Japanese women. Eur J Clin Nutr 2001;55:773-777. (Pubitemid 32834391)
10. Everitt JI, Wolf DC, Howe SR, Goldsworthy TL, Walker C. Rodent model of reproductive tract leiomyomata. Clinical and pathological features. Am J Pathol 1995;146:1556-1567.
11. Walker CL, Hunter D, Everitt JI. Uterine leiomyoma in the Eker rat: a unique model for important diseases of women. Genes Chromosomes Cancer 2003;38:349-356.
12. Howe SR, Gottardis MM, Everitt JI, Golesworthy TL, Wolf DC, Walker C. Rodent model of reproductive tract leiomyomata. Establishment and characterization of tumorderived cell lines. Am J Pathol 1995;146:1568-1579.
13. Severino MF, Murray MJ, Brandon DD, Clinton GM, Burry KA, Novy MJ. Rapid loss of oestrogen and progesterone receptors in human leiomyoma and myometrial explant cultures. Mol Hum Reprod 1996;2:823-828.
14. Houston KD, Copland JA, Broaddus RR, Gottardis MM, Fischer SM, Walker CL. Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferators - activated receptor g ligands in uterine leiomyoma. Cancer Res 2003;63:1221-1227.
15. Shushan A, Ben-Bassat H, Mishni E, Laufer N, Klein BY, Rojansky N. Inhibition of leiomyoma cell proliferation in vitro by genistein and the protein tyrosine kenase inhibitor TKS050. Fertil Steril 2007;87:127-135.
16. Gossner G, Choi M, Tan L, et al. Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells. Gynecol Oncol 2007;105:23-30. (Pubitemid 46441453)
17. Huang X, Chen S, Xu L, et al. Genistein inhibits p38 map kinase activation, matrix metalloproteinase type2, and cell invasion in human prostate epithelial cells. Cancer Res 2005; 65:3470-3478.
18. Katdare M, Osborne M, Telang NT. Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells. Int J Oncol 2002;21:809-815.
19. Dang ZC, Audinot V, Papapoulos SE, Boutin JA, Lowik CWGM. Peroxisome proliferator-activated receptor g (PPARg) as a molecular target for the soy phytoestrogen genistein. J Biol Chem 2003;278:962-967.
20. Setchell KD. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 1998;68(6 Suppl):1333S-1346S.
21. Izumi T, Piskula MK, Osawa S, Obata A, Tobe K, Saito M, Kataoka S, Kubota Y, Kikuchi M. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J Nutr 2000;130:1695-1699.
22. Sharma AM, Staels B. Review: peroxisome proliferatoractivated receptor g and adipose tissue - understanding obesity-related changes in the regulation of lipid and glucose metabolism. J Clin Endocrinol Metab 2007;92: 386-395.
23. Wright HM, Clish CB, Mikami T, Hauser S, Yanagi K, Hiramatsu R, Serhan CN, Spiegelman BM. A synthetic antagonist for the peroxisome proliferator-activated receptor g inhibits adipocyte differentiation. J Biol Chem 2000;275: 1873-1877.
24. Takeda T, Sakata M, Isobe A, Miyake A, Nishimoto F, Ota Y, Kamiura S, Kimura T. Relationship between metabolic syndrome and uterine leiomyomata: a case-control study. Gynecol Obstet Invest 2008;66:14-17.
25. Banerjee S, Li Y, Wang Z, Sarkar FH. Multi-targeted therapy of cancer by genistein. Cancer Lett 2008;269:226-242.